1. Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma
    Mohamed Aboshanif et al, 2016, Diagnostic Pathology CrossRef
  2. A common molecular signature of intestinal-type gastric carcinoma indicates processes related to gastric carcinogenesis
    Renata Binato et al, 2018, Oncotarget CrossRef
  3. Okamoto model for necrosis and its expansions, CD38-cyclic ADP-ribose signal system for intracellular Ca2+ mobilization and Reg (Regenerating gene protein)-Reg receptor system for cell regeneration
    Hiroshi OKAMOTO et al, 2021, Proceedings of the Japan Academy, Series B CrossRef
  4. Significance of Interleukin-6/STAT Pathway for the Gene Expression of REG Iα, a New Autoantigen in Sjögren’s Syndrome Patients, in Salivary Duct Epithelial Cells
    Takanori Fujimura et al, 2017, Clinical Reviews in Allergy & Immunology CrossRef
  5. Effect of resveratrol on cancer progression through the REG III expression pathway in head and neck cancer cells
    Shinji Mikami et al, 2016, International Journal of Oncology CrossRef
  6. Resveratrol Augments Doxorubicin and Cisplatin Chemotherapy: A Novel Therapeutic Strategy
    Ali Zarrabi et al, 2023, Current Molecular Pharmacology CrossRef
  7. Decreased REG1α expression suppresses growth, invasion and angiogenesis of bladder cancer
    J. Geng et al, 2017, European Journal of Surgical Oncology (EJSO) CrossRef
  8. Expression of REG family genes in human inflammatory bowel diseases and its regulation
    Chikatsugu Tsuchida et al, 2017, Biochemistry and Biophysics Reports CrossRef
  9. Role of regenerating gene IA expression on local invasion and survival in nasopharyngeal carcinoma
    Haijie Xing et al, 2017, Biological Research CrossRef
  10. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways
    Yuwei Wang et al, 2019, Cancer Biotherapy and Radiopharmaceuticals CrossRef
  11. Regenerating gene (REG) product and its potential clinical usage
    Shin Takasawa, 2016, Expert Opinion on Therapeutic Targets CrossRef